OpenResearchAlpha

Supportive Care in Cancer · 20 Nov 2026

Prospective digital neurocognitive and patient-reported symptom monitoring in adults scheduled for CAR T-cell therapy: feasibility and exploratory patient-level observations from a single-center cohort

Anna Fleischerh-index 4, Luna Dressler, Christofer Pohl, Onur Duman, Johannes Schobel, Carmen Sanges, Barbara Huber, Patrick-Pascal Strunz, Jessica Peter, Julia Mersi, Eleni Kakavela, K. Martin Kortüm, Johannes Waldschmidt, Sophia Danhof, Thomas Däullary, Leo Rasche, Johannes Düll, Götz Gelbrich, Hermann Einsele, Michael Hudecek, Max Topp, Imad Maatoukh-index 14

0
Citations
no database records one yet
0
Citations in 2026
so far
14
Leading author's h-index
Imad Maatouk, in QAI's scholar index
28
References
works it cites, from open citation data

Citations by database

Each database indexes a different set of journals, preprints and books, so they are shown side by side rather than blended.

  • OpenCitations0
  • Crossref0
  • Europe PMC0

Citations per year

The current year is still counting.

  • 2026 so far0

Abstract

Abstract Purpose To evaluate completion of individually tailored digital neurocognitive and symptom assessments in adults scheduled for CAR T-cell therapy and explore longitudinal changes in task-specific outcomes. Methods In this prospective single-center cohort (n = 33), NeuroCAT comprised 25 cognitive, visual, and graphomotor tasks and a symptom questionnaire at baseline (T0). At early post-infusion (T1) and pre-discharge (T2), investigators selected approximately eight tasks per participant. Results All 33 patients completed T0, and 30 (90.9%; Wilson 95% confidence interval, 76.4–96.9%) completed both T1 and T2 assessments. Two patients died before follow-up, and one did not undergo follow-up after interruption of the planned treatment pathway due to clinical instability. Paired quantitative T0/T2 observations were available for only 4-11 patients per task, with heterogeneous changes in task-specific indices and patient-reported symptoms. Among three patients with chart-documented grade 1 immune effector cell-associated neurotoxicity syndrome (ICANS), one had increased fatigue and neuropathic pain ratings and another had increased dizziness and concentration-difficulty ratings. Nonspecific symptom worsening was also observed in patients without ICANS. Conclusion Completion of individually assigned follow-up assessments was high among enrolled patients. Nonrandom task selection, limited paired observations, unvalidated task indices, and nonspecific symptom changes preclude conclusions about ICANS detection or clinical utility. Prospective validation is required. Relevance to supportive care Tailored digital assessments may support structured symptom documentation during CAR T-cell therapy, but patient burden and clinical value remain to be established.

What the data shows

  • No database records a citation yet, as is usual for a paper this new.
  • Imad Maatouk has the highest h-index among the authors (14).

Graph

This paper in the middle, its authors and their most-cited papers below, the papers it cites to the left and the papers citing it to the right. The timeline lays every paper out by year.

Citing paper shares an authorAuthor without a profileSize shows citations, or h-index for authors

Select a node for its details. Drag to pan, scroll to zoom, drag a node to move it.

Start with

Authors (22)

Each author's standing in QAI's scholar index: the works their ORCID iD is attached to, and for anyone whose ORCID record names a lab OpenResearch follows, their arXiv preprints matched by name and a shared co-author. Names are as printed on the paper.

ProfileMost-cited paper

Cited by 0 papers

Who cites this paper, from open citation data, with Crossref's record of each; the 100 newest when there are more.

0 shown
No citing papers for this filter.

References (28)

What it cites, from open citation data, with Crossref's record of each.

Sign in to see 8 more references

A free account opens the rest of the citing papers and references on every paper’s page.